EP3386548
Inósítól afleiða til notkunar við sjúkrafræðilega kristalmyndun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.12.2016EP published:
17.3.2021EP application number:
16819297.9
EP translation filed:
9.7.2021Grant published:
15.8.2021EPO information:
European Patent Register
Max expiry date:
11.12.2036Expiry date:
11.12.2025Next due date:
31.12.2025
Title:
INOSITOL DERIVATIVES FOR USE IN PATHOLOGICAL CRYSTALLIZATION
Timeline
Today
12.12.2016EP application
17.3.2021EP Publication
9.7.2021Translation submitted
15.8.2021Registration published
11.12.2025Expires
Owner
Name:
ETH ZürichAddress:
ETH Transfer Rämistrasse 101, 8092 Zürich, CH
Name:
Universität BernAddress:
Hochschulstrasse 4, 3012 Bern, CH
Inventor
Name:
IVARSSON, MattiasAddress:
8005 Zürich, CH
Name:
CASTAGNER, BastienAddress:
Montreal Québec H2J 387, CA
Name:
LEROUX, Jean-ChristopheAddress:
8053 Zürich, CH
Name:
PASCH, AndreasAddress:
3012 Bern, CH
Agent
Name:
Jesper Levin A/SAddress:
Jægersborg Allé 93, DK
Priority
Number:
15199682Date:
11.12.2015Country:
EP
Number:
16164299Date:
7.4.2016Country:
EP
Number:
16173422Date:
7.6.2016Country:
EP
Classification
Categories:
A61K 31/6615, A61K 47/60, A61P 3/14, A61P 9/00, A61P 13/02, A61P 17/00, A61P 19/06, A61P 19/08, A61P 19/10, A61P 35/00, C07F 9/06
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 16.12.2021
Expires: 11.12.2022
Payer: Patice ehf.
Number: 7
Paid: 22.12.2022
Expires: 11.12.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 15.12.2023
Expires: 11.12.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 13.12.2024
Expires: 11.12.2025
Payer: Árnason Faktor ehf.